Agile Therapeutics Inc. announced the launch of the women’s healthcare company’s first consumer commercial intended to increase awareness of the Twirla weekly birth control patch.

The biopharma industry and the U.S. Food and Drug Administration face a busy December with nine companies awaiting approval decisions.